期刊文献+

厦门地区儿科患者分离的产超广谱β-内酰胺酶大肠埃希菌耐药及基因型分析

Analysis on Drug Resistance and Genotypes of Escherichia coli Producing Extended Spectrum-beta-lactamase Isolated from Pediatric Patients in Xiamen Area
原文传递
导出
摘要 目的了解厦门地区儿科患者分离的产超广谱β-内酰胺酶(ESBLs)大肠埃希菌耐药及基因型情况,为临床防治提供对策。方法分析2011年1-12月解放军第174医院儿科住院患者中分离的产ESBLs大肠埃希菌的耐药情况,并采用特定引物PCR扩增的方法进行ESBLs基因亚型分析。结果 2011年全年共分离产ESBLs的大肠埃希菌189株,阳性率为19.73%(189/958),药敏结果显示除碳氢酶烯类抗生素、加酶抑制剂复合抗生素类、头霉素类抗生素等不同程度敏感外,其余抗生素均耐药;基因亚型主要为CTX-M-13,还有TEM型。结论厦门地区儿童患者产ES-BLs情况较为严重,应尽量避免不适当地应用三代头孢菌素、长期预防应用抗生素等。一旦发生感染,应有针对性地选用碳青霉烯类和头霉素类等使感染得以控制。 Objective To investigate the drug resistance and genotypes of Escherichia coli producing extended spectrum -beta-lactarnase (ESBLs) isolated from pediatric patients in Xiamen area, and to provide the countermeasures for the clinical prevention and treatment. Methods The drug resistance of Escherichia coli producing ESBLs isolated from pediatric inpa- tients of the 174th Hospital of Chinese PLA from January to December 2011 was analyzed. PCR amplification with specific prim- ers was used to detect the genotypes of ESBLs. Results A total of 189 strains of Escherichia coli producing ESBLs were iso- lated in 2011, with the positive rate of 19.73% (189/958). Drug sensitivity results showed that those strains were sensitive to carbapenem antibiotics, compound antibiotics of enzyme inhibitors and cephamycins antibiotics, but had varying degrees of resis- tance to other antibiotics tested. The gene subtypes of Escherichia coli producing ESBLs were mainly CTX- M- 13 and TEM. Conclusions The drug resistance of Escheri^hia coli producing ESBLs isolated from pediatric patients in Xiamen area was se- rious. Inappropriate application of the third generation cephalosporins and long- term preventive application of antibiotics should be avoided. Antibiotics like carbapenems and cephamycins should be used targetedly and timely in the patients with infections on the basis of the results of drug sensitivity.
出处 《实用预防医学》 CAS 2012年第11期1681-1683,共3页 Practical Preventive Medicine
基金 南京军区医药卫生项目(09MA060)
关键词 超广谱Β-内酰胺酶 儿童患者 耐药性 大肠埃希菌 基因型 Extended spectrum- beta- lactarnase Pediatric patient Drug resistance Escherichia coli Genotypes
  • 相关文献

参考文献12

  • 1Qin X,Zerr DM, Weissman SJ,et al. Prevalence and mechanisms ofbroad - spectrum beta - lactam resistance in Enterobacteriaceae : a chil-dren hospital experience[J]. Antimicrob Agents Chemother, 2008,52(11):3909-3914.
  • 2Skippen I, Shemko M, Turton J, et al. Epidemiology of infectionscaused by extended — spectrum beta — lactamase — producing Es-cherichia coli and Klebsiella spp. : a nested case — control study from atertiary hospital in London[ J]. J Hosp Infect, 2006, 64 (2) : 115 -123.
  • 3张晓兵,府伟灵,廖扬,陈斌,龚雅利.临床产ESBLs细菌的耐药特征和基因分型的研究[J].中华医院感染学杂志,2005,15(4):386-389. 被引量:42
  • 4黄宏君,吴白平.产超广谱β-内酰胺酶大肠埃希菌与肺炎克雷伯菌的耐药性研究[J].实用预防医学,2009,16(3):935-936. 被引量:2
  • 5Jayahar Bharathi M, Ramakrishnan R, Ramesh S, et al. Extended -spectrum beta — lactamase — mediated resistance among bacterial isolatesrecovered from ocular infections[J]. Ophthalmic Res, 2012,47(1) :52-56.
  • 6刘岚,郑玉强,赵昕,刘昌林,朱军,谢伟,景春梅.儿童临床产ESBLs菌基因型分布及其耐药特征的研究[J].重庆医科大学学报,2007,32(2):142-146. 被引量:8
  • 7石胜,熊燕.儿童患者中检出产ESBLs大肠埃希菌的耐药性和基因分型[J].中国热带医学,2007,7(11):2009-2010. 被引量:1
  • 8Pitout JD, Nordmann P, Laupland KB, et al. Emergence of Enter-obacterriaceae producing extended — spectrum — beta — lactmases (ES-BLs) in the community [J]. J Antimicrob Chemother, 2005,56: 52 —59.
  • 9Devrim I,Gulfidan G, Gunay I,et al. Comparison of in vitro activity ofertapenem with other carbapenems against extended — spectrum beta —lactamase 一 producing Escherichia coli and Kleibsella species isolated ina tertiary children,s hospital[J]. Expert Opin Pharmacother, 2011,12(6):845-849.
  • 10Rejiba S, Mercuri PS, Power P, et al. Emergence and dominance ofCTX — M — 15 extended spectrum beta — lactamase among Escherichiacoli isolates from jhildren[j]. Microb Drug Resist, 2011,17(2): 135-140.

二级参考文献26

  • 1张晓兵,府伟灵,廖扬,陈斌,龚雅利.临床产ESBLs细菌的耐药特征和基因分型的研究[J].中华医院感染学杂志,2005,15(4):386-389. 被引量:42
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S].9th informational supplement. Wayne, PA: NCCLS,1999.
  • 3Yagi T, Kurokawa H. A preliminary survey of extended-spectrum L-lactamases (ESBLs)in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan[J]. FEMS Microbiol Lett, 2000,184:54-55.
  • 4Knothe H, Shsh P, Kremery V, etal. Transferable to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens [J].Infection, 1983, 11:315.
  • 5Bradford PA.Extended-spectrum β-Lac-tamases in the 21stcentury,character-ization,epidemiology,and detection of this importantresistance threat[J].Clin Microbiol Rev,2001 ; 14:933-951.
  • 6Bush K,Jacoby G A,Medeiross A A.A functional classification scheme for 13-lactamases and correlation with molecaular structure[J].Antimicrob Agents Chemother, 1995 ;39(6) : 1211.
  • 7Lister PD, Gardner VM, Sanders CC.Clavulanate induces expression of the Pseudomonas aeruginosa Ampc cephalosporinase at phiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin[J].Antimicreb Agent Chemother, 1999;43 (4):882-889.
  • 8Blumer JL.Carbapenems in paediatrics[J].Scand J Infect Dis Suppl, 1995 ;96: 38-44.
  • 9Hughes WT,ArmstrongD,Bodey GP,et a1.1997 guidelines for the use of antimierobiai agents in neutropenie patients with unexplained fever[J].Clin Infect Dis, 1997: 25 : 551-573.
  • 10Johann D.D.Pitout,Patrice Nordmann,et al.Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases(ESBLs) in the community[J].J.Antimicrob.Chemother.,2005,56:52 - 59.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部